Filing Details
- Accession Number:
- 0001171843-17-005046
- Form Type:
- 5
- Zero Holdings:
- No
- Publication Time:
- 2017-08-14 16:03:14
- Reporting Period:
- 2017-06-30
- Filing Date:
- 2017-08-14
- Accepted Time:
- 2017-08-14 16:03:14
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 722830 | Immunomedics Inc | IMMU | In Vitro & In Vivo Diagnostic Substances (2835) | 611009366 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1202016 | L Cynthia Goldenberg | C/O Immunomedics, Inc. 300 The American Road Morris Plains NJ 07950 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-01-29 | 29,240 | $0.00 | 850,064 | No | 4 | A | Direct | |
| Common Stock | Disposition | 2017-01-29 | 11,696 | $4.65 | 850,064 | No | 4 | F | Direct | |
| Common Stock | Acquisiton | 2017-01-29 | 29,239 | $0.00 | 5,118,579 | No | 4 | A | Indirect | See Footnote |
| Common Stock | Disposition | 2017-01-29 | 11,696 | $4.65 | 5,118,579 | No | 4 | F | Indirect | See Footnote |
| Common Stock | Acquisiton | 2017-03-14 | 14,620 | $0.00 | 850,064 | No | 4 | A | Direct | |
| Common Stock | Disposition | 2017-03-14 | 5,848 | $6.39 | 850,064 | No | 4 | F | Direct | |
| Common Stock | Acquisiton | 2017-03-14 | 14,620 | $0.00 | 5,118,579 | No | 4 | A | Indirect | See Footnote |
| Common Stock | Disposition | 2017-03-14 | 5,848 | $6.39 | 5,118,579 | No | 4 | F | Indirect | See Footnote |
| Common Stock | Acquisiton | 2017-05-18 | 9,500 | $3.28 | 850,064 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-05-18 | 9,500 | $7.38 | 850,064 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2017-05-19 | 9,500 | $3.28 | 850,064 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-05-19 | 9,500 | $7.40 | 850,064 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2017-05-22 | 9,500 | $3.28 | 850,064 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-05-22 | 9,500 | $7.45 | 850,064 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2017-05-25 | 86,500 | $3.28 | 850,064 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-05-25 | 86,500 | $7.42 | 850,064 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2017-05-25 | 85,000 | $3.28 | 850,064 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2017-05-18 | 11,500 | $3.28 | 5,118,579 | No | 4 | M | Indirect | See Footnote |
| Common Stock | Disposition | 2017-05-18 | 11,500 | $7.38 | 5,118,579 | No | 4 | S | Indirect | See Footnote |
| Common Stock | Acquisiton | 2017-05-19 | 11,500 | $3.28 | 5,118,579 | No | 4 | M | Indirect | See Footnote |
| Common Stock | Disposition | 2017-05-19 | 11,500 | $7.34 | 5,118,579 | No | 4 | S | Indirect | See Footnote |
| Common Stock | Acquisiton | 2017-05-22 | 11,500 | $3.28 | 5,118,579 | No | 4 | M | Indirect | See Footnote |
| Common Stock | Disposition | 2017-05-22 | 11,500 | $7.45 | 5,118,579 | No | 4 | S | Indirect | See Footnote |
| Common Stock | Acquisiton | 2017-05-25 | 109,000 | $3.28 | 5,118,579 | No | 4 | M | Indirect | See Footnote |
| Common Stock | Disposition | 2017-05-25 | 109,000 | $7.43 | 5,118,579 | No | 4 | S | Indirect | See Footnote |
| Common Stock | Acquisiton | 2017-05-25 | 106,500 | $3.28 | 5,118,579 | No | 4 | M | Indirect | See Footnote |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | F | Direct | |
| No | 4 | A | Indirect | See Footnote |
| No | 4 | F | Indirect | See Footnote |
| No | 4 | A | Direct | |
| No | 4 | F | Direct | |
| No | 4 | A | Indirect | See Footnote |
| No | 4 | F | Indirect | See Footnote |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Indirect | See Footnote |
| No | 4 | S | Indirect | See Footnote |
| No | 4 | M | Indirect | See Footnote |
| No | 4 | S | Indirect | See Footnote |
| No | 4 | M | Indirect | See Footnote |
| No | 4 | S | Indirect | See Footnote |
| No | 4 | M | Indirect | See Footnote |
| No | 4 | S | Indirect | See Footnote |
| No | 4 | M | Indirect | See Footnote |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $0.01 Per Share | Stock Option (right to buy) | Disposition | 2017-05-18 | 9,500 | $0.00 | 9,500 | $3.28 |
| Common Stock, Par Value $0.01 Per Share | Stock Option (right to buy) | Disposition | 2017-05-19 | 9,500 | $0.00 | 9,500 | $3.28 |
| Common Stock, Par Value $0.01 Per Share | Stock Option (right to buy) | Disposition | 2017-05-22 | 9,500 | $0.00 | 9,500 | $3.28 |
| Common Stock, Par Value $0.01 Per Share | Stock Option (right to buy) | Disposition | 2017-05-25 | 86,500 | $0.00 | 86,500 | $3.28 |
| Common Stock, Par Value $0.01 Per Share | Stock Option (right to buy) | Disposition | 2017-05-25 | 85,000 | $0.00 | 85,000 | $3.28 |
| Common Stock, Par Value $0.01 Per Share | Stock Option (right to buy) | Disposition | 2017-05-18 | 11,500 | $0.00 | 11,500 | $3.28 |
| Common Stock, Par Value $0.01 Per Share | Stock Option (right to buy) | Disposition | 2017-05-19 | 11,500 | $0.00 | 11,500 | $3.28 |
| Common Stock, Par Value $0.01 Per Share | Stock Option (right to buy) | Disposition | 2017-05-22 | 11,500 | $0.00 | 11,500 | $3.28 |
| Common Stock, Par Value $0.01 Per Share | Stock Option (right to buy) | Disposition | 2017-05-25 | 109,000 | $0.00 | 109,000 | $3.28 |
| Common Stock, Par Value $0.01 Per Share | Stock Option (right to buy) | Disposition | 2017-05-25 | 106,500 | $0.00 | 106,500 | $3.28 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 190,500 | 2017-07-23 | No | 4 | M | Direct | |
| 181,000 | 2017-07-23 | No | 4 | M | Direct | |
| 171,500 | 2017-07-23 | No | 4 | M | Direct | |
| 85,000 | 2017-07-23 | No | 4 | M | Direct | |
| 0 | 2017-07-23 | No | 4 | M | Direct | |
| 238,500 | 2017-07-23 | No | 4 | M | Indirect | |
| 227,000 | 2017-07-23 | No | 4 | M | Indirect | |
| 215,500 | 2017-07-23 | No | 4 | M | Indirect | |
| 106,500 | 2017-07-23 | No | 4 | M | Indirect | |
| 0 | 2017-07-23 | No | 4 | M | Indirect |
Footnotes
- Represents the settlement of common stock underlying Performance Units that have vested in accordance with the terms of the Performance-Based Restricted Stock Unit Agreement entered into by and between the Company and the reporting person on August 16, 2013.
- Includes a total of 190,000 shares held as joint tenants by the reporting person and her spouse, David M. Goldenberg, the Issuer's Chief Scientific Officer and Chief Patent Officer.
- Such shares are held by the reporting person's spouse, by various trusts established for the benefit of the reporting person and/or family members of the reporting person, or by a majority-owned subsidiary of the Issuer, of which the reporting person is an officer. The reporting person disclaims beneficial ownership of these shares except to the extent of her pecuniary interests therein.
- The reporting person was granted stock options pursuant to the Company's 2006 Stock Incentive Plan, as amended. Such stock options vested 25% on the first anniversary of the date of grant and 6.25% on a quarterly basis thereafter.
- The reporting person's spouse, Dr. David M. Goldenberg, was granted stock options pursuant to the Company's 2006 Stock Incentive Plan, as amended. Such stock options vested 25% on the first anniversary of the date grant and 6.25% on a quarterly basis thereafter.
Billionaire Hedge Funds
